West Pharmaceutical (WST) news
Recent news
West Pharmaceutical Services, Inc.: Barclays raises target price to $440 from $400
Barclays has raised its price target for West Pharmaceutical Services, Inc. (WST) to $440 from $400, while maintaining its "Overweight" rating for the stock . This adjustment reflects growing confidence in the company’s performance and prospects. The stock closed at $372.64 on October 6, 2026, with…
AInvest Wire · 7d agoESG stocks rose in regular trading, with West Pharmaceutical Services up 2.5%, Trimble gaining 2.3% and Edwards Lifesciences rising 2.3%.
On October 5, 2026, ESG-focused stocks saw gains in regular trading, reflecting continued investor interest in sustainability-oriented equities. West Pharmaceutical Services (WPH) rose 2.5%, Trimble (TRMB) advanced 2.3%, and Edwards Lifesciences (EW) climbed 2.3%. These movements align with broader…
AInvest Wire · Oct 5, 2026West Pharmaceutical Services Inc.: Morgan Stanley raises to overweight from equal-weight
AInvest Wire · Sep 22, 2026West Pharmaceutical Services Inc.: Morgan Stanley raises target price to $400.00 from $365.00
AInvest Wire · Sep 22, 2026Waystar shares up 4% after Reuters reports co explores options including sale
Waystar Inc. (WST) shares rose approximately 4% in early trading on September 15, 2026, following a report by Reuters that the company is exploring strategic options, including a potential sale . The report indicated that the company has engaged financial advisors to evaluate various possibilities,…
AInvest Wire · Sep 15, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.